Stocktoria

BIODESIX INC BDSX

Nasdaq · stock · Services-Medical Laboratories · website · IPO 2020-10-28

BIODESIX INC statistics & valuation

Market cap$241.7M
P / S2.7×
Net margin-39.8%
FCF margin-26.6%
Net debt$31.0M
Enterprise value USD$272.7M
Earnings yield EBIT/EV-10.2%
Return on capital-39.8%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-125.10% -143.70% -79.20% -171.30% -106.20% -60.20% -39.80% 2019202020212022202320242025
Gross margin (%)
2019202020212022202320242025
Operating margin (%)
-108.90% -50.30% -75.10% -132.40% -84.20% -48.40% -31.50% 2019202020212022202320242025
Return on equity (%)
-159.00% -218.80% -317.60% -1138.60% -205.60% 2019202020212022202320242025
Shares outstanding
254918 26.6M 30.8M 77.6M 96.2M 7.3M 8.3M 2019202020212022202320242025
Net debt ($)
-$34.0M -$22.6M -$13.0M $13.8M $13.8M $31.0M 2019202020212022202320242025
Share buybacks ($)
2019202020212022202320242025
Return on assets (%)
-68.20% -54.10% -56.70% -70.40% -52.60% -44.10% -40.30% 2019202020212022202320242025
Free cash flow margin (%)
-93.80% -51.20% -55.90% -126.30% -93.30% -72.70% -26.60% 2019202020212022202320242025
Debt / equity (×)
0.68× 0.51× 1.46× 8.75× 1.92× 2019202020212022202320242025
EPS ($)
-$1.58 -$1.55 -$0.64 -$6.64 -$4.67 2019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Operating margin-31.5%-48.4%-84.2%-132.4%-75.1%-50.3%-108.9%
Net margin-39.8%-60.2%-106.2%-171.3%-79.2%-143.7%-125.1%
FCF margin-26.6%-72.7%-93.3%-126.3%-55.9%-51.2%-93.8%
Return on assets-40.3%-44.1%-52.6%-70.4%-56.7%-54.1%-68.2%
Return on equity1430.6%-205.6%-1138.6%-317.6%-218.8%-159.0%13.6%
Debt / equity-20.29×1.92×8.75×1.46×0.51×0.68×—
Current ratio1.862.761.192.341.512.680.56

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.